Elastomer Change Out-Justification for Minimizing the Removal of Elastomers To Prevent Cross-Contamination in a Multiproduct Facility
PDA J Pharm Sci Technol
.
2018 Jan-Feb;72(1):81-90.
doi: 10.5731/pdajpst.2016.007484.
Epub 2017 Sep 19.
Authors
Michael Parks
1
,
Niamh O'Dwyer
1
,
Jeremy Bollinger
2
,
Alan Johnson
3
,
Brian Goss
4
,
Ned Wyman
5
,
Adeyma Arroyo
6
,
Joseph Wood
6
,
Derek Willison-Parry
7
Affiliations
1
Pfizer.
2
Biogen.
3
Amgen.
4
Lilly.
5
AstraZeneca.
6
Genentech/Roche.
7
BPOG
[email protected]
.
PMID:
28928292
DOI:
10.5731/pdajpst.2016.007484
No abstract available
MeSH terms
Drug Contamination / prevention & control*
Drug Industry / instrumentation
Drug Industry / methods*
Elastomers / isolation & purification*
Humans
Reproducibility of Results
Substances
Elastomers